Development of AVID100, a novel antibody-drug conjugate for the treatment of EGFR expressing solid tumors

被引：4
|
作者：
O'Connor-McCourt, M. [1 ]
Koropatnick, J. [2 ]
Maleki, S. [2 ]
Figueredo, R. [2 ]
Tikhomirov, I. [3 ]
Jaramillo, M. [4 ]
机构：
[1] Format Biol, R&D, Montreal, PQ, Canada
[2] Lawson Hlth Res Inst, Canc Res Program, London, ON, Canada
[3] Format Biol, R&D, Houston, TX USA
[4] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)33037-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
450
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [41] DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis
    Wu, Yangping
    Li, Wenting
    Chen, Xiangzheng
    Wang, Haichuan
    Su, Siyuan
    Xu, Ying
    Deng, Xiangbing
    Yang, Tinghan
    Wei, Mingtian
    Li, Li
    Liu, Yixin
    Yang, Jinliang
    Li, Weimin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors
    Hu, Yixuan
    Zhu, Yinxing
    Wei, Xiaowei
    Tang, Cuiju
    Zhang, Wenwen
    DRUGS OF TODAY, 2022, 58 (10) : 491 - 507
  • [43] SGN-PDL1V, A NOVEL, INVESTIGATIONAL PD-L1-DIRECTED ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF SOLID TUMORS
    Kwan, Byron
    Ramirez, Megan
    Jin, Steven
    Yu, Changpu
    Wo, Serena
    Gupta, Priyanka
    Allred, Sean
    Simmons, Jessica
    Hensley, Kelly
    de Zafra, Christina Zuch
    Neff-LaFord, Haley
    Hengel, Shawna
    Forero-Torres, Andres
    Van Epps, Heather
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A818 - A818
  • [44] Novel antibody-drug conjugates targeting ADAM9-expressing solid tumors demonstrate potent preclinical activity
    Hicks, Stuart W.
    Yoder, Nicholas C.
    Loo, Deryk
    Muvaffak, Asli
    Zhou, Yinghui
    Fuller, Megan E.
    McShea, Molly A.
    Themeles, Marian
    Mucciarone, Katherine H.
    Scribner, Juniper A.
    Barat, Bhaswati
    Sun, Thomas
    Tamura, James
    Chen, Francine Z.
    Donahue, Kerry A.
    Chittenden, Tom
    CANCER RESEARCH, 2017, 77
  • [45] Antibody-drug conjugate and novel therapy in lung cancer
    Cho, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1310 - S1311
  • [46] DEPATUXIZUMAB MAFODOTIN Anti-EGFR antibody-drug conjugate Treatment of glioblastoma multiforme MONOGRAPH
    Gajdosik, Z.
    DRUGS OF THE FUTURE, 2016, 41 (04) : 217 - 220
  • [47] Development of novel MUC1-C targeting antibody-drug conjugate for pancreatic cancer treatment
    Ahmad, Rehan
    Panchamoorthy, Govind
    Raina, Deepak
    Lawney, Brian
    Kharbanda, Surender
    Jasuja, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] A novel CD30-directed antibody-drug conjugate for the treatment of lymphomas
    Hamblett, Kevin J.
    Jin, Steven
    Yumul, Roma
    Chen, Yufei
    Kwon, John
    Simmons, Jessica
    Henderson, Clark
    Sun, Hao
    Schrum, Jason P.
    Lim, Andrea R.
    Bindman, Noah A.
    Canerly, Melissa
    Clarke, Astrid
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [49] Preclinical Characterization of XB002, an Anti-Tissue Factor Antibody-Drug Conjugate for the Treatment of Solid Tumors
    Kantak, Seema
    Faggioni, Raffaella
    Cai, Allen G.
    Bhatti, Maryam M.
    Li, Jing
    Vainshtein, Inna
    Cheng, Jackie
    Mendelsohn, Brian A.
    Gaudreault, Jacques
    Migone, Thi-Sau
    Theunissen, Jan-Willem
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (02) : 251 - 260
  • [50] Developing a novel doppel-targeting antibody-drug conjugate (ADC) for solid cancer
    Lee, Ha Kyeong
    Kim, Byoungmo
    Kweon, Seho
    Choi, Jeong Uk
    Kim, Sang Yoon
    Byun, Youngro
    CANCER RESEARCH, 2023, 83 (07)
12345